<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Blizard Institute of Cell and Molecular</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/69F244EE-43E2-418E-930E-4A56BC1A6C46"><gtr:id>69F244EE-43E2-418E-930E-4A56BC1A6C46</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>Dubois</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700545"><gtr:id>4D3C6BA0-9526-489E-9EFA-E9E263A1BD97</gtr:id><gtr:title>Functional investigation of inflammatory intestinal disease susceptibility genes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700545</gtr:grantReference><gtr:abstractText>Recent advances in human genetics (Human Genome Project, HapMap Project, technology) now enable us to study most of the common genetic variation that makes us different from one another. By comparing people with and without disease in a genome wide association study, genes can be pinpointed that predispose to common intestinal inflammatory diseases (coeliac disease, Crohn?s disease, ulcerative colitis). A recent success has been the identification of genetic variants in IL23R (a protein involved in inflammation) and the confirmation of NOD2 as genes predisposing to Crohn?s disease. The challenge is then to understand how genetic variation leads to changes in biology. We have previously done this for NOD2 in Crohn?s disease. We have preliminary data using human samples on how we might show that IL23R genetic variation has an effect on immune system function, and the development of Crohn?s disease and other autoimmune diseases. Initially the project will study IL23R, later ATG16L1, then possibly a further gene arising from the genome wide association studies. Studying the biology of how genetic variants influence inflammatory diseases will have implications for novel therapeutics and diagnostics for these diseases, leading to better treatments.</gtr:abstractText><gtr:technicalSummary>Aims
Advances in human genetics now enable for the first time identification of primary genetic variants predisposing to common inflammatory intestinal diseases (coeliac disease, Crohn?s disease and ulcerative colitis). Early successes include NOD2, IBD5/5q31 and IL23R variants predisposing to Crohn?s disease. However only for NOD2 have we begun to understood how genetic variation might influence biological function and cause intestinal inflammation. Genome wide association studies are currently in progress in coeliac disease (our group) and Crohn?s disease/ulcerative colitis (at least three groups worldwide). These will shortly uncover many further disease predisposing genetic variants. The sim is to understand how these influence biological function.

Objectives
Convincingly replicated genetic variants from the current genome wide studies in intestinal inflammatory diseases will be identified. A range of techniques will be used to understand how genetic variation influences biological function, and might lead to intestinal inflammation. We have previously performed such studies for NOD2, and have preliminary data for IL23R. It is proposed the Fellow will initially investigate IL23R, later ATG16L1, and possibly a further disease gene arising from the genome wide association studies.

Design
Studies will be primarily performed using human samples, from healthy controls and from patients with intestinal disease. Although animal models exist, these often poorly reflect human intestinal biology. Human samples will include cell lines, fresh peripheral blood, histological archive intestinal tissue, and fresh surgical small/large intestinal specimens. Precise studies will depend on the biological function of the gene containing disease associated genetic variation. In general, we will first understand the normal function of the gene (extensive literature search, if necessary descriptive experiments). Second an assay for gene function will be developed and comin disease versus health, and sub-stratified by genetic variation. The key endpoint will be how different genotypes at a locus influence biological function. 

Methodology
Descriptive (e.g. gene expression at mRNA, protein level in tissue/cell samples; bioinformatics). Quantitative (e.g. for NOD2 muramyl dipeptide induced peripheral blood IL-8 response; for IL23R activated peripheral blood / lamina propria T cell cytokine dose response to IL23). Comparison between disease and controls, substratified by genotype. We have published using this methodology for NOD2, and have are developing assays for IL23R.

Scientific and Medical Opportunities
Detailed understanding of how disease associated genetic variants alter biological function will provide insight into primary causes of disease. This will enable targeted development of novel therapeutic strategies, and better treatments for patients.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>198555</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Exeter</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical School</gtr:department><gtr:description>PRED4: Predicting serious drug side effects in gastroenterology</gtr:description><gtr:id>6F9BDA6A-DAD5-4B7E-962A-C77130270A6D</gtr:id><gtr:impact>Nil yet- study ongoing</gtr:impact><gtr:outcomeId>FqQbQS2sJFu-1</gtr:outcomeId><gtr:partnerContribution>Partner is now leading this study</gtr:partnerContribution><gtr:piContribution>I performed a pilot genome wide association study of Thiopurine Induced Pancreatitis in Inflammatory Bowel Disease patients. This collaboration builds on that work, by recruiting more patients to a similar study. This will have greater power to identify genetic risk variants in Thiopurine Induced Pancreatits, I have been involved in the design of the study, and will continue to contribute through advising on phenotyping and analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>6BD1D301-3CC0-46AF-B3FB-8EE44687A27E</gtr:id><gtr:impact>Around 150 members of Coeliac UK Harrow group attended a talk (to which I had been invited) about my genetics research in coeliac disease. This sparked considerable interest and questions afterwards

I have been invited to talk at another Coeliac UK branch meeting (Huntingdon) in December 2010.</gtr:impact><gtr:outcomeId>WNYAiae1q1T</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in Coeliac UK magazine- Crossed Grain</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>93FAA4E8-1037-4B26-969B-522EA3B2C3BC</gtr:id><gtr:impact>Article explaining outcomes of research done in our group on discovery of genetic susceptibility variants in coeliac disease, to which I am participating (although main funding was not from MRC)

Article was accompanied by an advert for coeliac patients to participate in further susceptibility gene discovery studies done in our group. ~1500 patients have contributed samples</gtr:impact><gtr:outcomeId>38A198D881D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A Talk to Immunogenetics Laboratory, National Blood Service</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2738FECE-3752-4B59-8A1C-DB8364F21C7D</gtr:id><gtr:impact>Talk about HLA genotyping and uses in coeliac disease diagnosis.

As a result, the laboratory performing HLA genotyping for coeliac disease in the region has changed its reporting practices significantly and now avoids prevoius ambiguities/innaccuracies that were present</gtr:impact><gtr:outcomeId>VLPTrkduHQD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Institute for Child Health, Great Ormond Street Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A3285F71-D1E7-4FC9-AE5B-F92AD1F771B3</gtr:id><gtr:impact>~100 individuals attended (mainly paediatricians and dieticians). I talked about genetics of coeliac disease and applicatiosn to clinical practice. Generated a lot of discussion and questions after. Positive written feedback. Invited to talk again next year

Invited to talk again</gtr:impact><gtr:outcomeId>P9q5hVYF9Zn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I have collected together DNA samples from individuals who have experienced a serious adverse effect (pancreatitis) of the immunosuppressant medications azathioprine and 6-mercaptopurine. This collection includes locally recruited samples and samples collected from invited collaborators in the UK, Netherlands, Spain and New Zealand</gtr:description><gtr:id>6B7AB51A-BC61-40F7-B1B3-AE2D71766DF8</gtr:id><gtr:impact>This collection has enabled a genome-wide association study of genetic risk variants in this phenotype- a large part funded by this grant, and has led to the discovery of the first known genetic variants influencing risk of this adverse effect in individuals exposed to azathioprine or 6-mercaptopurine. Manuscript is in preparation.</gtr:impact><gtr:outcomeId>J3wAoVdXWhN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DNA samples from individuals with Azathioprine-induced pancreatitis</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9E2E86C1-99FC-4C3D-97F3-0E4A8C545E4A</gtr:id><gtr:title>Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e32a4b9f9495ad715f10996e8155ce9f"><gtr:id>e32a4b9f9495ad715f10996e8155ce9f</gtr:id><gtr:otherNames>Trynka G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5461264f3b7916.61428674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AED52661-4C73-426D-AAFD-C649726F4BF5</gtr:id><gtr:title>Genetic risk variants in intestinal inflammatory disorders</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98ff9d8ec94de4ff5baa5618b299f4e7"><gtr:id>98ff9d8ec94de4ff5baa5618b299f4e7</gtr:id><gtr:otherNames>Dubois Patrick Charles Alexander</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>i6PtrsT4cw3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC9FAF1E-5B50-4ED9-9F01-BA84FD74A382</gtr:id><gtr:title>Genome-wide analysis of allelic expression imbalance in human primary cells by high-throughput transcriptome resequencing.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fb8b35143d2c3224157d16285969e98"><gtr:id>4fb8b35143d2c3224157d16285969e98</gtr:id><gtr:otherNames>Heap GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>DXYEpYYYZRB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>104C49EF-959E-41FB-BEDE-0BDA42B5BB6F</gtr:id><gtr:title>Multiple common variants for celiac disease influencing immune gene expression.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7a351133b1ced7c51fea309803ba2dc"><gtr:id>e7a351133b1ced7c51fea309803ba2dc</gtr:id><gtr:otherNames>Dubois PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>JxxxiAjDepo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A043D4BC-3C15-4203-ACAD-57EB46F89D5E</gtr:id><gtr:title>Association study of the IL18RAP locus in three European populations with coeliac disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e4c8906e46942ac8347a29952d89ec9"><gtr:id>9e4c8906e46942ac8347a29952d89ec9</gtr:id><gtr:otherNames>Koskinen LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>GKxsZNs4XQv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64FC3377-4BBD-4D0E-B538-F70BA3DB80C0</gtr:id><gtr:title>Oxford Textbook of Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1e8e289c8f5f1b297de15efca2d5e8e"><gtr:id>b1e8e289c8f5f1b297de15efca2d5e8e</gtr:id><gtr:otherNames>Dubois, Patrick and van Heel, David</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:isbn>978-0199204854</gtr:isbn><gtr:outcomeId>rWitRWGYa5z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77B1B7BE-2058-4357-9342-E6D0B83DCC97</gtr:id><gtr:title>Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5461268786cd28.58483483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94EA7B7D-5085-4CE2-B8B2-7601ED0185AD</gtr:id><gtr:title>A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a833cd221424d61e9208e140541c9bea"><gtr:id>a833cd221424d61e9208e140541c9bea</gtr:id><gtr:otherNames>Festen EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pPdfnj2CAT3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F53E928C-F11E-4F26-8C12-BDBB29BEA4D8</gtr:id><gtr:title>Shared and distinct genetic variants in type 1 diabetes and celiac disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d89f19b204fc719bf56a44424ce8bf6"><gtr:id>1d89f19b204fc719bf56a44424ce8bf6</gtr:id><gtr:otherNames>Smyth DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>D1ULz8Vc9W6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E47E8AE-0C1F-4BB4-86E9-186229A7F2B6</gtr:id><gtr:title>Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5311357a23c1c0fc7830d8108dd6ce9"><gtr:id>a5311357a23c1c0fc7830d8108dd6ce9</gtr:id><gtr:otherNames>Zhernakova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>KBMLg1w2wMW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>585D3FCF-832F-4383-94BD-7DF0DE015573</gtr:id><gtr:title>HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fb8b35143d2c3224157d16285969e98"><gtr:id>4fb8b35143d2c3224157d16285969e98</gtr:id><gtr:otherNames>Heap GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5461260c066fc3.46575393</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700545</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>